Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Meningioma × Tablets × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 17 Neoplasms 9 Polycystic Ovary Syndrome 7 Multiple Myeloma 4 Vomiting 3 Prostatic Neoplasms 3 Neoplasm Metastasis 3 Melanoma 3 Leukemia, Myeloid, Acute 3 Head and Neck Neoplasms 3 Endometrial Neoplasms 3 Triple Negative Breast Neoplasms 2 Solid Tumors 2 Recurrence 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Obesity 2 Nausea 2 Lung Neoplasms 2 Leukemia, Lymphocytic, Chronic, B-Cell 2 Leukemia, B-Cell 2 Leukemia 2 Insulin Resistance 2 Inflammation 2 Colorectal Neoplasms 2 Cardiotoxicity 2 Weight Gain 1 Venous Thromboembolism 1 Uterine Cervical Neoplasms 1 Uterine Cervical Dysplasia 1 Urinary Bladder Neoplasms 1

Interventions

Magnetic Resonance Spectroscopy 13 Everolimus 7 lutetium Lu 177 dotatate 6 Proton Therapy 6 Hydroxyurea 6 gallium Ga 68 dotatate 5 Specimen Handling 5 Bevacizumab 5 Radiosurgery 4 Cyclophosphamide 4 pembrolizumab 3 Tranexamic Acid 3 Temozolomide 3 Surgical Procedures, Operative 3 Sunitinib 3 Radiotherapy, Intensity-Modulated 3 Nivolumab 3 Imatinib Mesylate 3 90Y-octreotide, DOTA-Tyr(3)- 3 trametinib 2 fludarabine 2 arginyllysine 2 aldesleukin 2 Yoga 2 Whole Body Imaging 2 Surveys and Questionnaires 2 Sodium Chloride 2 Radiotherapy, Conformal 2 Protons 2 Paclitaxel 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06275919 2025-03-13

MIRAGE

Istituto Oncologico Veneto IRCCS

Phase 2 Recruiting

Meningioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡